Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and Thromboembolism

9 Dec 2020

Abstract excerpt

COVID-19 is caused by Severe Acute Respiratory Syndrome Coronavirus-2, which has infected over thirty eight million individuals worldwide. Emerging evidence indicates that COVID-19 patients are at a high risk of developing coagulopathy and thrombosis, conditions that elevate levels of D-dimer. It is believed that homocysteine, an amino acid that plays a crucial role in coagulation, may also contribute to these...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers in Disease Mechanisms
Share to Cardiovascular Disease and Adiposity
Share to COVID-19 Clinical Research Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33362545
DOI: 10.3389/fphar.2020.587451

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and ThromboembolismPMID 33362545Read ↗

Genome-wide cross-trait analysis and Mendelian randomization reveal a shared genetic etiology and causality between COVID-19 and venous thromboembolismSemantic proximity Read ↗

Contribution of genotypes in Prothrombin and Factor V Leiden to COVID-19 and disease severity in patients at high risk for hereditary thrombophilia.Semantic proximity Read ↗

Single- and Multimarker Genome-Wide Scans Evidence Novel Genetic Risk Modifiers for Venous Thromboembolism.Semantic proximity Read ↗

Shared genetic etiology and causality between COVID-19 and venous thromboembolism: evidence from genome-wide cross trait analysis and bi-directional Mendelian randomization studySemantic proximity Read ↗

What is currently known about the genetics of venous thromboembolism at the dawn of next generation sequencing technologies.Semantic proximity Read ↗

Polygenic predisposition to venous thromboembolism is associated with increased COVID-19 positive testing ratesSemantic proximity Read ↗

Venous thromboembolic disease genetics: from variants to function.Semantic proximity Read ↗

Human genetics implicate thromboembolism in the pathogenesis of long COVID in individuals of European ancestrySemantic proximity Read ↗

GENETIC DETERMINANTS OF THROMBOSIS.Semantic proximity Read ↗

Genome-wide association analysis of self-reported events in 6135 individuals and 252 827 controls identifies 8 loci associated with thrombosis.Semantic proximity Read ↗

Genome-wide meta-analysis identifies 93 risk loci and enables risk prediction equivalent to monogenic forms of venous thromboembolism.Semantic proximity Read ↗

Prediction of Venous Thromboembolism Based on Clinical and Genetic FactorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.